Labor and DeliveryNCT02803450
Epidural Loading: High Volume, Low Concentration
A study testing Epidural needle and Catheter Administration in people with Labor and Delivery, run by Ohio State University at 1 site in United States.
Trial summary
This prospective, randomized, single blinded control trial will investigate the effects of epidural loading with a high volume, low concentration local anesthetic solution via the epidural needle versus the epidural catheter. Read more about this study
- Who is it for?
- Ages 18 to 89 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Labor and Delivery
- What is being tested?
- Epidural needle and Catheter Administration
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- Feb 2016to Jan 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 89 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Subjects who have volunteered and consented to participation in the study upon admission to labor and delivery
- Parturients in active labor requesting epidural analgesia
- Uncomplicated pregnancy with a reassuring fetal heart tracing
- Age greater than or equal to 18 years
Who cannot join
- Contraindication to epidural anesthesia
- Inability to read, comprehend, and sign the informed consent form
- Fetal intrauterine growth retardation (IUGR)
- Non-reassuring fetal heart tracing
- Cervical dilation greater than 7cm
- Intra-uterine fetal demise
Show all 9Show fewer
- History of chronic pain other than in the back
- Incarcerated patients I. Any patient enrolled in the study in whom there is evidence of dural puncture during epidural technique (>3 attempts, presence of CSF)
- Any evidence of high spinal after initial bolus or continuous infusion of high volume, low concentration local anesthetic solution k. Women undergoing cesarean section
Trial locations and contacts
1 site in 1 country.
United States1 site
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210
About this study
Official title: Epidural Loading With High Volume, Low Concentration Prior to Catheter Insertion: is How You Administer the Volume Important?
This prospective, randomized, single blinded control trial will investigate the effects of epidural loading with a high volume, low concentration local anesthetic solution via the epidural needle versus the epidural catheter.
Read the detailed description
This prospective, randomized, single blinded control trial will investigate the effects of epidural loading with a high volume, low concentration local anesthetic solution via the epidural needle versus the epidural catheter. Control patients will receive local anesthetic in lower volume more concentrated solution via the epidural catheter which is current standard practice. Outcome measures will include quantifying pain relief with respect to time using VAS scores. In addition, post delivery patient satisfaction regarding anesthesia regimen, blood pressure changes, heart rate, anesthetic level, total dose of epidural used during labor, rescue doses and incidence of fetal bradycardia will be assessed. 35 patients will be recruited for each of the three arms of the study, totaling 105 patients, in order to obtain significance when performing statistical analyses following complete enrollment in the study. The impetus of this study involves investigation of the effects of loading the epidural space with high volume, low concentration local anesthetic via two different modalities and studying which method is more efficacious.
- Conditions
- Labor and Delivery
- Being tested
- Epidural needle, Catheter Administration, Standard of Care Epidural Administration
- Keywords
- Effects of; Anesthesia, spinal and epidural
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Epidural needleProcedure or surgery
Medication administration via epidural needle.
Catheter AdministrationProcedure or surgery
Medication administration via epidural catheter.
Standard of Care Epidural AdministrationProcedure or surgery
Also called Epidural catheter
Medication administered at higher concentration, lower volume via epidural catheter.
| Study group | Role | What they receive |
|---|---|---|
| High Volume, Low Concentration via Epidural Needle | Experimental | Epidural loading: Participants will receive 20ml of 0.0625% bupivacaine with fentanyl 1mcg/ml epidural loading dose in 10ml increments five minutes apart via epidural needle followed by catheter placement.
For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.03125% bupivacaine with 1mcg/ml fentanyl. The infusion rate will be set at 20ml/hr basal rate and 8ml every 15 minutes on demand with lockout of 52ml/hr.
For inadequate analgesia: One additional 10ml boluses of the experimental 0.0625% bupivacaine with 1mcg/ml will be provided spaced 5 minutes apart via the epidural catheter. Receives: Procedure: Epidural needle |
| High Volume, Low Concentration via Epidural Catheter | Experimental | Epidural loading: Participants will receive 20ml of 0.0625% bupivacaine with fentanyl 1mcg/ml epidural loading dose in 10ml increments five minutes apart via the epidural catheter administration following catheter placement.
For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.03125% bupivacaine with 1mcg/ml fentanyl. The infusion rate will be set at 20ml/hr basal rate and 8ml every 15 minutes on demand with lockout of 52ml/hr.
For inadequate analgesia: One additional 10ml boluses of the experimental 0.0625% bupivacaine with 1mcg/ml will be provided spaced 5 minutes apart via the epidural catheter. Receives: Procedure: Catheter Administration |
| Low Volume, High Concentration via Epidural Catheter | Active comparator | Standard of Care Epidural Administration Epidural loading: Participants will receive 10ml of 0.125% bupivacaine with fentanyl 2mcg/ml in 5 ml increments 5 minutes apart via the epidural catheter following epidural catheter placement, per standard of care.
For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.0625% bupivacaine with 2mcg/ml fentanyl. The infusion rate will be set at 10ml/hr basal rate and 4ml every 15 minutes on demand with lockout of 26ml/hr.
For inadequate analgesia: One additional 5ml boluses of the standard 0.125% bupivacaine with 2mcg/ml will be provided spaced 5 minutes apart via the epidural catheter. Receives: Procedure: Standard of Care Epidural Administration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient Pain Levels (VAS Assessment)
Patients will be assessed for pain levels on the VAS scale after analgesia administration in both arms
Measured: During Labor
Patient Satisfaction
Patient satisfaction with analgesia using a Likert rating of patient satisfaction with anesthetic care.
Measured: During labor
Secondary outcomes (5)
Analgesic level
Pinprick every 10, 15, and 20 minutes following loading
Measured: 20 minutes
Maternal Vital Signs
Measure change in maternal blood pressure and heart rate over 20 minutes following loading.
Measured: 20 minutes
Fetal Heart Rate
Measure change in fetal heart rate following loading.
Measured: 20 minutes
Rescue Bolus
Measure number of rescue bolus doses and total anesthetic dose
Measured: During Labor
Intravascular Catheter Placement
Measure incidence of intravascular catheter placement.
Measured: During labor
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jun 2016 (estimated)
- Study startFeb 2016
- Primary completionJan 2017
- Study completionJan 2017
Why it stopped: The protocol will be rewritten.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Labor and DeliveryStudies of the same condition, open and under way.
- More trials run by Ohio State UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ohio State University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Goran Ristev, Ohio State University
- Investigators
- Goran Ristev, MD, Principal investigator, The Ohio State Univeristy
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02803450
- Sponsor's protocol ID
- 2013H0188
- Status last verified
- Sep 2021
- First submitted
- 14 Jun 2016
- Last updated
- 27 Sep 2021
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Sep 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Epidural Loading With High Volume, Low Concentration Prior to Catheter Insertion: is How You Administer the Volume Important?
- ClinicalTrials.gov ID
- NCT02803450
- Acronym / sponsor ID
- 2013H0188
- Conditions
- Labor and Delivery
- Keywords
- Effects of; Anesthesia, spinal and epidural
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: The protocol will be rewritten.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Ohio State UniversityUniversity, hospital or other
- Study start
- Feb 2016
- Primary completion
- Jan 2017 (actual)
- Study completion
- Jan 2017 (actual)
- First posted
- 17 Jun 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective, randomized, single blinded control trial will investigate the effects of epidural loading with a high volume, low concentration local anesthetic solution via the epidural needle versus the epidural catheter.
Detailed description
This prospective, randomized, single blinded control trial will investigate the effects of epidural loading with a high volume, low concentration local anesthetic solution via the epidural needle versus the epidural catheter. Control patients will receive local anesthetic in lower volume more concentrated solution via the epidural catheter which is current standard practice. Outcome measures will include quantifying pain relief with respect to time using VAS scores. In addition, post delivery patient satisfaction regarding anesthesia regimen, blood pressure changes, heart rate, anesthetic level, total dose of epidural used during labor, rescue doses and incidence of fetal bradycardia will be assessed. 35 patients will be recruited for each of the three arms of the study, totaling 105 patients, in order to obtain significance when performing statistical analyses following complete enrollment in the study. The impetus of this study involves investigation of the effects of loading the epidural space with high volume, low concentration local anesthetic via two different modalities and studying which method is more efficacious.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| High Volume, Low Concentration via Epidural Needle | Experimental | Procedure: Epidural needleEpidural loading: Participants will receive 20ml of 0.0625% bupivacaine with fentanyl 1mcg/ml epidural loading dose in 10ml increments five minutes apart via epidural needle followed by catheter placement. For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.03125% bupivacaine with 1mcg/ml fentanyl. The infusion rate will be set at 20ml/hr basal rate and 8ml every 15 minutes on demand with lockout of 52ml/hr. For inadequate analgesia: One additional 10ml boluses of the experimental 0.0625% bupivacaine with 1mcg/ml will be provided spaced 5 minutes apart via the epidural catheter. |
| High Volume, Low Concentration via Epidural Catheter | Experimental | Procedure: Catheter AdministrationEpidural loading: Participants will receive 20ml of 0.0625% bupivacaine with fentanyl 1mcg/ml epidural loading dose in 10ml increments five minutes apart via the epidural catheter administration following catheter placement. For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.03125% bupivacaine with 1mcg/ml fentanyl. The infusion rate will be set at 20ml/hr basal rate and 8ml every 15 minutes on demand with lockout of 52ml/hr. For inadequate analgesia: One additional 10ml boluses of the experimental 0.0625% bupivacaine with 1mcg/ml will be provided spaced 5 minutes apart via the epidural catheter. |
| Low Volume, High Concentration via Epidural Catheter | Active comparator | Procedure: Standard of Care Epidural AdministrationStandard of Care Epidural Administration Epidural loading: Participants will receive 10ml of 0.125% bupivacaine with fentanyl 2mcg/ml in 5 ml increments 5 minutes apart via the epidural catheter following epidural catheter placement, per standard of care. For continuous infusions: The continuous patient controlled epidural anesthesia (PCEA) pump will contain 0.0625% bupivacaine with 2mcg/ml fentanyl. The infusion rate will be set at 10ml/hr basal rate and 4ml every 15 minutes on demand with lockout of 26ml/hr. For inadequate analgesia: One additional 5ml boluses of the standard 0.125% bupivacaine with 2mcg/ml will be provided spaced 5 minutes apart via the epidural catheter. |
Who may qualify
- Ages
- 18 to 89 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Subjects who have volunteered and consented to participation in the study upon admission to labor and delivery
- Parturients in active labor requesting epidural analgesia
- Uncomplicated pregnancy with a reassuring fetal heart tracing
- Age greater than or equal to 18 years
Key exclusion criteria (9 listed)
- Contraindication to epidural anesthesia
- Inability to read, comprehend, and sign the informed consent form
- Fetal intrauterine growth retardation (IUGR)
- Non-reassuring fetal heart tracing
- Cervical dilation greater than 7cm
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Epidural needleMedication administration via epidural needle. | Procedure or surgery | High Volume, Low Concentration via Epidural Needle |
| Catheter AdministrationMedication administration via epidural catheter. | Procedure or surgery | High Volume, Low Concentration via Epidural Catheter |
| Standard of Care Epidural AdministrationAlso: Epidural catheterMedication administered at higher concentration, lower volume via epidural catheter. | Procedure or surgery | Low Volume, High Concentration via Epidural Catheter |
Primary outcome
Patient Pain Levels (VAS Assessment)
Time frame: During Labor
Patients will be assessed for pain levels on the VAS scale after analgesia administration in both arms
Patient Satisfaction
Time frame: During labor
Patient satisfaction with analgesia using a Likert rating of patient satisfaction with anesthetic care.
5 secondary outcomes
Analgesic level
Time frame: 20 minutes
Maternal Vital Signs
Time frame: 20 minutes
Fetal Heart Rate
Time frame: 20 minutes
Rescue Bolus
Time frame: During Labor
Intravascular Catheter Placement
Time frame: During labor
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Sep 2021.
- Individual participant dataSharing planned: No
Related trials for Labor and Delivery
Enrolling by invitationObservational study
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Acute Kidney Injury, Fluid Overload
Recruiting
The Effect of Breast Milk, 10% and 20% Dextrose on Pain and Physiological Variables During Heel Puncture in Infants
Newborn Care, Pain Management
Active, not recruiting
Prone Positioning During Delayed Cord Clamping
Delayed Cord Clamping
Not yet recruiting
The Hemodynamic Impact of High-frequency Oscillatory Ventilation and Periodic Sighs in Preterm Infants
Preterm, Respiratory Distress Syndrome in Premature Infant
RecruitingPhase 3
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
Sepsis, PROM, Preterm (Pregnancy)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Goran Ristev, MD principal investigator
The Ohio State Univeristy
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Epidural needle and Catheter Administration in people with Labor and Delivery, run by Ohio State University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 27 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient Pain Levels (VAS Assessment) (time frame: During Labor). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2021.